White Fund
White Fund is a venture capital firm based in Liège, Belgium, that specializes in early-stage investments in the medical devices and medtech sectors. The firm focuses on projects that demonstrate proof of concept and show objective market traction. White Fund supports the pre-marketing phases of these projects and the subsequent launch of sales. It typically invests between €2 million and €3 million in each venture, spread across two to three financing rounds. The firm's investment strategy is primarily centered on Belgium but may extend to neighboring regions. With an exit target of five to seven years, White Fund is dedicated to fostering innovation in the medical device sector.
moveUP develops and commercialise digital therapeutics solutions. Its closed loop system enables high compliance, better outcome and satisfaction. It uses continuously collected data to directly personalise the treatment of the patient. Its first therapy treats orthopaedic patients undergoing a joint surgery. It has CE medical device & ISO 13485 certification.
Endo Tools Therapeutics S.A., established in 2008 and based in Gosselies, Belgium, is a medical device company focused on creating innovative therapeutic devices for gastroenterologists. The company develops a triangulation platform known as ENDOMINA, which facilitates therapeutic procedures in gastroenterology. Additionally, Endo Tools Therapeutics is working on a catheter designed to enhance interventional gastroenterology by introducing therapeutic channels and increased maneuverability. Its product offerings include endoscopic devices aimed at treating obesity, digestive tract tumors, and diabetes, specifically targeting flexible endoscopic suturing and tissue apposition. These advancements enable gastroenterologists to perform surgical endoscopy more effectively, improving patient outcomes in various digestive tract procedures.
Antelope Dx BV develops diagnostic platform and device that allows consumers and healthcare professionals to undergo tests in home setting. It offers Antelope Diagnostic STD-Test, which is a urine-based self-test, allowing the concerned individual to directly test for the presence of the most common sexually transmitted diseases (STD), Chlamydia trachomatis (CT), and Neisseria gonorrhoeae (NG). The company focuses on developing tests in fields such as, home, point of care, animal health, and drug development. Antelope Dx BV was founded in 2018 and is based in Zwijnaarde, Belgium.